A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MS
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Jacobs, MD
Vice President
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Grodno Regional Clinical Hospital
Grodno, Belarus
- Minsk City Clinical Hospital #5
Minsk, Belarus
- Minsk Scientific and Practical Center of Surgery, Transplantology and Hematology
Minsk, Belarus
- Republican Research and Development Center for Neurology and Neurosurgery
Minsk, Belarus
- Vitebsk Regional Diagnostic Center
Vitebsk, Belarus
- University Clinical Centre of the Republic of Srpska, Clinic of Neurology
Banja Luka, Bosnia and Herzegovina
- University Clinical Hospital Mostar, Clinic of Neurology
Mostar, Bosnia and Herzegovina
- Multiprofile Hospital for Active Treatment - Pleven Within the Structure of Military Medical Academy, Sofia
Pleven, Bulgaria
- University Multiprofile Hospital for Active Treatment "dr. Georgi Stranski", Pleven, Clinic of Neurological Diseases
Pleven, Bulgaria
- Medical Center "rusemed" Eood
Rousse, Bulgaria
- Multiprofile Hospital for Active Treatment "acibadem City Clinic Tokuda Hospital", Sofia, Neurology and Sleep Medicine Clinic
Sofia, Bulgaria
- Multiprofile Hospital for Active Treatment of Neurology and Psychiatry "sveti Naum", Sofia
Sofia, Bulgaria
- University Multiprofile Hospital for Active Treatment "sveti Ivan Rilski", Sofia, Clinic of Neurology Diseases
Sofia, Bulgaria
- Clinical Hospital Center Osijek, Clinic of Neurology
Osijek, Croatia
- Clinical Hospital Center Rijeka, Department of Neurology
Rijeka, Croatia
- General Hospital Varazdin, Department of Neurology
Varaždin, Croatia
- Clinical Hospital Dubrava, Department of Neurology
Zagreb, Croatia
- Institute for Emergency Medicine
Chisinau, Moldova
- National Institute of Neurology and Neurosurgery
Chisinau, Moldova
- Dendryt Medical Center
Katowice, Poland
- Neuro-Medic
Katowice, Poland
- Neurology Center Krzysztof Selmaj
Lodz, Poland
- Medical Practice Professor K. Rejdak
Lublin, Poland
- Med-Polonia, Sp. Z O.O. (llc)
Poznan, Poland
- "medyk" Stanislaw Mazur Sp. Z O.O. (llc) Medical Centre
Rzeszów, Poland
- Neuroprotect Medical Center
Warsaw, Poland
- Clinical Center of Serbia
Belgrade, Serbia
- Clinical Hospital Center Zemun, Department of Neurology
Belgrade, Serbia
- Clinical Hospital Center Zvezdara
Belgrade, Serbia
- Clinical Center Kragujevac
Kragujevac, Serbia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Jan 2018
- Primary completion
- 3 Dec 2018
- Completion
- 2 Jan 2019
- Last update posted
- 15 Jul 2022
- Registered enrollment
- 536
- Registry id
- NCT03290131
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.